Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Norris

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
Oncotarget|April 19, 2016
Use of a MCL-1 inhibitor alone to de-bulk melanoma and in combination to kill melanoma initiating cellsNabanita Mukherjee, Yan Lu, Adam Almeida, et al.
The Journal of Investigative Dermatology|March 31, 2015
Narrow Band Ultraviolet B Treatment for Human Vitiligo Is Associated with Proliferation, Migration, and Differentiation of Melanocyte PrecursorsNathaniel B Goldstein, Maranke I Koster, Laura G Hoaglin, et al.
Cell Death & Disease|March 8, 2024
MCL1 inhibition targets Myeloid Derived Suppressors Cells, promotes antitumor immunity and enhances the efficacy of immune checkpoint blockadeNabanita Mukherjee, Elizabeth Katsnelson, Tonya M Brunetti, et al.
Pharmaceuticals (Basel, Switzerland)|August 28, 2021
A Novel Regimen for Treating Melanoma: MCL1 Inhibitors and AzacitidineChiara R Dart, Nabanita Mukherjee, Carol M Amato, et al.
JCI Insight|October 5, 2018
High-throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in alopecia areataAnnemieke de Jong, Ali Jabbari, Zhenpeng Dai, et al.
Stem Cells (Dayton, Ohio)|August 14, 2012
ALDH1A isozymes are markers of human melanoma stem cells and potential therapeutic targetsYuchun Luo, Katiuscia Dallaglio, Ying Chen, et al.
Pigment Cell & Melanoma Research|February 12, 2024
Vitiligo non-responding lesions to narrow band UVB have intriguing cellular and molecular abnormalities that may prevent epidermal repigmentationNathaniel B Goldstein, Andrea Steel, Landon Tomb, et al.
Cell Death & Disease|September 7, 2018
BH3 mimetics induce apoptosis independent of DRP-1 in melanomaNabanita Mukherjee, Andrew Strosnider, Bay Vagher, et al.
The Journal of Investigative Dermatology|December 23, 2021
Expression Differences in BCL2 Family Members between Uveal and Cutaneous Melanomas Account for Varying Sensitivity to BH3 MimeticsNabanita Mukherjee, Chiara R Dart, Carol M Amato, et al.
The Journal of Investigative Dermatology|August 25, 2024
Phosphodiesterase-4 Inhibitors Increase Pigment Cell Proliferation and Melanization in Cultured Melanocytes and within a 3-Dimensional Skin Equivalent ModelNathaniel B Goldstein, Zachary B K Berk, Landon C Tomb, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Oncotarget|April 19, 2016
Use of a MCL-1 inhibitor alone to de-bulk melanoma and in combination to kill melanoma initiating cellsNabanita Mukherjee, Yan Lu, Adam Almeida, et al.
The Journal of Investigative Dermatology|March 31, 2015
Narrow Band Ultraviolet B Treatment for Human Vitiligo Is Associated with Proliferation, Migration, and Differentiation of Melanocyte PrecursorsNathaniel B Goldstein, Maranke I Koster, Laura G Hoaglin, et al.
Cell Death & Disease|March 8, 2024
MCL1 inhibition targets Myeloid Derived Suppressors Cells, promotes antitumor immunity and enhances the efficacy of immune checkpoint blockadeNabanita Mukherjee, Elizabeth Katsnelson, Tonya M Brunetti, et al.
Pharmaceuticals (Basel, Switzerland)|August 28, 2021
A Novel Regimen for Treating Melanoma: MCL1 Inhibitors and AzacitidineChiara R Dart, Nabanita Mukherjee, Carol M Amato, et al.
JCI Insight|October 5, 2018
High-throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in alopecia areataAnnemieke de Jong, Ali Jabbari, Zhenpeng Dai, et al.
Stem Cells (Dayton, Ohio)|August 14, 2012
ALDH1A isozymes are markers of human melanoma stem cells and potential therapeutic targetsYuchun Luo, Katiuscia Dallaglio, Ying Chen, et al.
Pigment Cell & Melanoma Research|February 12, 2024
Vitiligo non-responding lesions to narrow band UVB have intriguing cellular and molecular abnormalities that may prevent epidermal repigmentationNathaniel B Goldstein, Andrea Steel, Landon Tomb, et al.
Cell Death & Disease|September 7, 2018
BH3 mimetics induce apoptosis independent of DRP-1 in melanomaNabanita Mukherjee, Andrew Strosnider, Bay Vagher, et al.
The Journal of Investigative Dermatology|December 23, 2021
Expression Differences in BCL2 Family Members between Uveal and Cutaneous Melanomas Account for Varying Sensitivity to BH3 MimeticsNabanita Mukherjee, Chiara R Dart, Carol M Amato, et al.
The Journal of Investigative Dermatology|August 25, 2024
Phosphodiesterase-4 Inhibitors Increase Pigment Cell Proliferation and Melanization in Cultured Melanocytes and within a 3-Dimensional Skin Equivalent ModelNathaniel B Goldstein, Zachary B K Berk, Landon C Tomb, et al.
Pageof 8